AllianceBernstein’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-63,300
Closed -$135K 3246
2025
Q1
$135K Hold
63,300
﹤0.01% 3017
2024
Q4
$246K Sell
63,300
-6,930
-10% -$55.2K ﹤0.01% 2966
2024
Q3
$709K Sell
70,230
-12,310
-15% -$80K ﹤0.01% 2483
2024
Q2
$371K Buy
82,540
+53,400
+183% +$543K ﹤0.01% 2829
2024
Q1
$436K Hold
29,140
﹤0.01% 2638
2023
Q4
$423K Buy
29,140
+4,060
+16% +$49.3K ﹤0.01% 2691
2023
Q3
$345K Buy
25,080
+5,420
+28% +$97.7K ﹤0.01% 2747
2023
Q2
$432K Buy
+19,660
New +$615K ﹤0.01% 2715

Other funds holding BMEA

AllianceBernstein's BMEA Position: Q2 2025 in Review

AllianceBernstein sold out of Biomea Fusion (BMEA) in Q2 2025, closing a stake of 63,300 shares — an estimated $135K sold.

AllianceBernstein first reported a position in BMEA in Q2 2023 and held it in 8 quarters. The position peaked at $709K in Q3 2024. 87 funds tracked by Wall St. Rank hold BMEA as of Q2 2025.

  • AllianceBernstein reported no remaining Biomea Fusion position as of Q2 2025 after selling out during the quarter.
  • AllianceBernstein sold 63,300 Biomea Fusion shares in Q2 2025, an estimated $135K.
  • AllianceBernstein first reported a position in Biomea Fusion in Q2 2023 and held it in 8 quarters.
  • AllianceBernstein's Biomea Fusion position peaked at $709K in Q3 2024.
  • 87 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2025.

Based on AllianceBernstein's 13F filing for Q2 2025, filed 14 Aug 2025.